Articles tagged with Drug Discovery
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
The article discusses how reperfusion injury amplifies cell damage after tissue perfusion. Calcium handling mechanisms, including Ca2+ ion elevation, predispose patients to mitochondrial failure, hyper-contracture, and proteolysis.
A study by the University of São Paulo's Biomedical Science Institute shows that sofosbuvir can eliminate both chikungunya and yellow fever viruses without damaging human cells. This finding has significant implications for public health, particularly in Brazil where a chikungunya epidemic is forecasted.
A new study assesses the reliability of CETSA HT for early drug discovery, demonstrating good correlations with other assay formats. The technology highlights different compound responses, providing a better understanding of cellular effects.
Researchers at Weizmann Institute of Science have revealed a previously unknown mechanism underlying anxiety. Targeting this biochemical pathway may help develop new therapies for alleviating the symptoms of anxiety disorders.
Ruiwen Zhang, a University of Houston College of Pharmacy scientist, has been recognized as a leader in cancer prevention and treatment drug discovery and development. He has made major contributions to the discovery of cancer pharmacogenetic/pharmacogenomic syndrome and developed novel gene silencing technologies.
Researchers found that metformin and syrosingopine combination blocks critical energy production step, driving cancer cells to death. The duo targets NAD+ regeneration, preventing lactate export and leading to cell demise.
A comprehensive review highlights novel approaches to slow or prevent Alzheimer's disease, focusing on the effects of aging on the brain. Combination therapy is deemed necessary for better treatment outcomes, similar to other major diseases.
A new research developed a platform to predict compounds with clinical potential for treating brain diseases. The platform uses machine learning and whole-brain activity imaging to identify drugs with higher therapeutic and clinical translation potential, accelerating the drug development process.
A recent paper by Insilico Medicine introduces deep learning for aging research, revealing age as a key biological feature that can be predicted using various data types. The study also outlines the potential applications of this technology, including personalized immunotherapies and vaccinations.
Researchers use cryo-electron microscopy to capture detailed snapshots of the TFIID molecule's dynamic structure as it interacts with DNA. The high-resolution images reveal new insights into the molecular mechanism and provide opportunities for developing drugs that target its structural changes.
Researchers at Colorado State University have created a new carbon-carbon bond reaction using phosphorus to stitch together molecular rings called pyridines. This reaction could fling open an underexplored wing of biologically relevant chemistry, allowing for the discovery of new drugs.
Researchers at UCI School of Medicine have discovered the molecular basis for therapeutic actions of an African folk medicine used to treat various illnesses, including diabetes and epilepsy. The study found two components of the Mallotus leaf extract bind to a previously unrecognized binding site on KCNQ1 potassium channels.
A multidisciplinary research team has provided fundamental new insight into the mechanism of dimethyl fumarate, a medical drug used to treat multiple sclerosis and psoriasis. The results describe an allosteric covalent inhibition of p90 ribosomal S6 kinases, pointing to an effective mechanism of kinase inhibition.
Researchers at Kanazawa University have identified three new compounds from the leaves of a threatened tropical plant species with potent antiproliferative activities against various human tumor cell lines. The study highlights the potential of rainforest plants as a rich source of bioactive natural products for cancer drug discovery.
Researchers at University of Montreal discovered how metformin affects cell glucose uptake and metabolism, revealing a link to iron distribution. This finding may explain metformin's potential benefits beyond diabetes treatment, including prevention of chronic diseases like cancer.
Purdue researchers, including Nobel Prize winner Ei-ichi Negishi, developed a new chemical process to synthesize drug-like molecules with ultra-high purity. The technology produces high yields and has a broad scope for use among boron-based drugs.
The special issue brings together contributions from top academics and industry experts, highlighting the use of generative chemistry and GANs for de-novo molecular design. Experimental validation of generated molecules demonstrates high activity and selectivity in a novel inhibitor of Janus Kinase 3.
Researchers found a new mechanism involving KCNB1 potassium channels that builds up toxins in brains affected by Alzheimer's disease. The build-up is caused by oxidation and can also contribute to other conditions such as traumatic brain injury.
Researchers at OHSU have discovered the three-dimensional structure of a membrane channel critical in controlling blood pressure. The breakthrough provides a starting point for developing better treatments for diseases associated with this channel, including severe hypertension and heart failure.
Researchers at GC/CUNY have made a major breakthrough in controlling the 3D structure of molecules, enabling the rapid modification of molecular structures used in drug discovery. This new process offers tremendous promise for developing novel drug molecules with medicinal or industrial applications.
The research collaboration aims to create human organs-on-chips using miniature devices that mimic specific tissues and organs. These organs-on-chips have the potential to predict drug activity and toxicity more accurately than animal models.
Researchers at Sanford Burnham Prebys Medical Discovery Institute have found that amodiaquine suppresses blood vessel formation through both the apelin and VEGF pathways, reversing vascular eye damage in animal models. The compound blocks the receptor's function by binding to a unique area, inhibiting apelin's ability to drive blood ve...
Researchers at Insilico Medicine developed an Entangled Conditional Adversarial Autoencoder (ECAAE) that generates molecular structures based on various properties. The generated molecule demonstrated high activity and selectivity against a specific protein, laying the foundation for AI-powered drug discovery.
Pharmaceutical companies are adopting improved safety screening strategies to enhance the drug discovery process, including integrated screening paradigms and computational methods. These approaches aim to identify higher-quality drug candidates and mitigate off-target toxicity.
Researchers at UTSA made a groundbreaking discovery involving the regulation of thiols in mammals. The study found that human bodies may be capable of breaking fluorine-carbon bonds in drugs, opening new possibilities for pharmaceutical treatments.
Researchers have crystallized serotonin receptors bound to several compounds, revealing why some drugs cause severe side effects while others do not. The study provides valuable insight into the receptor's structure and binding mechanisms, enabling drug developers to create safer and more effective medications.
Researchers at the University of Zurich have developed a new method for alleviating chronic itch by targeting specific neurons in the spine that prevent itch signals from being relayed to the brain. The experimental drug has been shown to be effective in mice and dogs, with significant reductions in scratching and improved skin healing.
The Harrington Discovery Institute has announced three new scholars in collaboration with FFB and ADDF, selected through a competitive review process for their research on therapies for retinal degenerative diseases and Alzheimer's disease. The institute provides financial support and drug development assistance to accelerate these pro...
Scripps Research scientists have developed a powerful new strategy for synthesizing molecular skeletons of chemicals used in drugs and other important products. The method combines two chemical reactions, C-C cross coupling and cycloaddition, providing unprecedented flexibility and control over chemical synthesis.
A new compound with potential to treat visceral leishmaniasis has been discovered through collaboration between the University of Dundee, GSK and Wellcome. The compound works by inhibiting an enzyme called CRK12, offering a novel approach to tackling the disease.
This special issue showcases recent advances in high-throughput flow cytometry for drug discovery, including novel applications and expert insights. Examples include HTFC for single-cell analysis, biologic drugs, and CAR-T therapy.
Researchers at the University of Pennsylvania and Syracuse University have developed a compound that effectively controls hyperglycemia in animal trials without causing nausea and vomiting. The modified compound is less absorbed into brain regions that trigger these side effects, leading to vastly improved tolerance.
Researchers at Cardiff University have developed a potential new treatment for schistosomiasis and fascioliasis, two devastating tropical diseases. The goji berry-derived drug compound shows promise in combating the parasites that cause these conditions.
Scientists have identified two small-molecule compounds that specifically target the STING protein, which plays a key role in triggering an immune response. These compounds effectively blocked STING-mediated cellular activation and demonstrated therapeutic potential in mouse models of autoinflammatory disease.
Researchers at University of Otago have discovered a novel property of Bedaquiline, a new anti-tuberculosis drug that could help develop more effective treatments for tuberculosis. The study's findings suggest that the drug works by disrupting energy generation in Mycobacterium tuberculosis cells, offering potential for designing more ...
Insilico Medicine introduces a novel deep neural network architecture called Reinforced Adversarial Neural Computer (RANC) for de novo molecular design. RANC outperforms other methods in generating unique structures and passing medical chemistry filters.
A new study by Scripps Research reveals that bacteria-derived molecules called thiocarboxylic acids have potential as warheads and could be used to create more effective drugs. The discovery was made after researchers found that these natural products can bind to biological targets better than lab-made molecules.
AcuraStem has been awarded a $3.7 million SBIR grant to continue research on a small molecule therapeutic for ALS, utilizing induced motor neuron cellular models and precision platform iNeuroRx°. The grant supports the development of AS2015, targeting expansion repeats in the C9ORF72 gene.
A recent international agreement emphasizes the need for human-relevant research in drug discovery, citing a significant decline in successful new drug approvals. The agreement proposes standardized data sharing, consistent ontologies, and prioritization of human-based methods to revitalize the drug development process.
Researchers at UBC's Okanagan campus found that men who have used psychedelic drugs are less likely to engage in partner violence. The study suggests that psychedelics may help improve emotion regulation and reduce violent tendencies.
Clinical Trials in a Dish (CTiD) offers a novel strategy to test drugs on patient cells before moving into actual clinical trials. CTiD studies have opened up new avenues for screening cell-based safety and toxicity at the population level, enabling efficient testing with reduced costs.
Researchers discovered a chemical compound that lowers sugar levels as effectively as metformin but with a 30-times lower dose, providing an alternative treatment option for patients unresponsive to the current medication. The study published in PLOS One could lead to the development of a new and effective drug to fight diabetes.
Researchers have found a link between bacteria metabolism and cell-to-cell communication, which could lead to the development of new drugs that block toxic molecules or prevent biofilm formation. By disrupting quorum sensing and biofilm forming in bacteria, these drugs may prevent infections such as urinary tract infections.
The study reveals unexpected molecular behavior in ultra-nanoscale channels, where neutral molecules behave as though carrying a charge. The team developed an algorithm for selecting optimal nanochannel size for each drug, but found that current theories were unable to explain the observed effects.
Researchers at Duke University have developed a technique to capture RNA molecules in precise images, revealing new opportunities for drug discovery. The method identifies potential anti-HIV compounds from millions of possibilities, showcasing its accuracy and potential to treat various ailments.
Eight out of ten transformative medicines in the US between 1985 and 2009 originated from fundamental discoveries, with an average time to approval of 30 years. Curiosity-driven science is essential for discovering new medicines.
Researchers have discovered an alternative strategy to combat antimicrobial resistance by repositioning colloidal bismuth subcitrate, which effectively paralyzes multi-resistant superbugs and suppresses the development of antibiotic resistance. The findings offer a promising new approach to treat deadly infections caused by CRE and CRKP.
Researchers at Nagoya University have successfully determined the crystal structure of the gastric proton pump, a key enzyme in stomach acid secretion. The study sheds light on how the pump expels hydrogen ions into the stomach despite its acidic environment.
Biogerontology Research Foundation's Chief Science Officer, Professor Alexander Zhavoronkov, will share his projections on how AI is set to revolutionize biopharma for aging and biomarker discovery. He will reveal the latest progress in AI and drug discovery at Pioneers18 in Vienna.
Researchers at Trinity College Dublin have discovered a potential 'off-switch' for inflammation by identifying the molecule itaconate, which can block production of inflammatory factors and protect against lethal inflammation. This breakthrough could lead to new anti-inflammatory medicines for diseases such as arthritis and heart disease.
A study discovered that an experimental drug connected to fat regulation prevents the formation of kidney stones in mice. The researchers found that the β3-agonist reduced inflammation in kidneys by consuming free fatty acids, potentially preventing both obesity and kidney stones. Further studies are needed to confirm these findings.
LSU researchers developed a computer-assisted drug repositioning process to identify existing drugs for rare diseases. They matched protein structures and functions with existing drug interactions to help patients receive effective treatment.
Researchers at TSRI have developed a new desulfonylative cross-coupling reaction that simplifies the synthesis of drug-like molecules, including alkyl-fluorinated compounds. This method paves the way for creating new types of compounds and facilitating the synthesis of pharmaceuticals.
University of Alberta researchers have found the Ebola polymerase enzyme, which may lead to more effective research and better treatments for the often fatal infection. The discovery allows for the study of Ebola inhibitors in any lab environment, accelerating the search for antiviral medicines.
Researchers at Australian National University have identified molecular similarities across six pharmaceutical drugs to reduce unwanted side effects. The study, published in Proceedings of the National Academy of Sciences, aims to inform future scientists on how to design more specific drugs with fewer side effects.
Researchers propose roadmap for making humans resistant to radiation and stress damage, with a focus on radioresistance. The strategies aim to maximize productive life years in space, addressing challenges like high-LET radiation.
McMaster University engineers have developed a printed paper-based device that speeds up and improves the accuracy of drug screening. The technology uses a printable hydrogel to filter out inaccurate results, reducing the time and cost associated with drug discovery.
Researchers at U of T have designed a new antimicrobial material to minimize recurrent caries under fillings, affecting 100 million patients annually. The novel material packs 50 times more bacteria-fighting drugs than traditional options, offering a potential solution to this common dental problem.
Researchers at University of Toronto have developed technology for creating durable disease-fighting molecules that can last longer in the body, reducing frequent drug injections. Mirror-image versions of existing drugs, such as GLP1 and PTH, have been created using computational approach, showing longer-lasting effects on cells.
Researchers at University of Bristol have successfully trapped objects larger than the wavelength of sound in an acoustic tractor beam, paving the way for levitation of humans. The discovery uses rapidly fluctuating acoustic vortices, which are stabilised by controlling the rate of rotation.